Patents by Inventor Henry D. Cremisi

Henry D. Cremisi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110081385
    Abstract: Compositions and methods for the regulation of sleep and circadian rhythms are provided. The compositions are nutritional supplements containing melatonin and one or more vitamins that enhance the effectiveness of melatonin. Preferred vitamins include folic acid, riboflavin (vitamin B2), cobalamin (vitamin B12) or pyridoxine (vitamin B6). The compositions beneficially and advantageously regulate sleep when administered to an individual and are administered to a human or animal suffering from an irregular sleep or circadian rhythm or are administered in anticipation of the development of such an irregularity.
    Type: Application
    Filed: June 10, 2010
    Publication date: April 7, 2011
    Applicant: LifeScape BioSciences Inc.
    Inventor: Henry D. Cremisi
  • Patent number: 7799817
    Abstract: Compositions and methods for the regulation of sleep and circadian rhythms are provided. The compositions are nutritional supplements containing melatonin and one or more vitamins that enhance the effectiveness of melatonin. Preferred vitamins include folic acid, riboflavin (vitamin B2), cobalamin (vitamin B12) or pyridoxine (vitamin B6). The compositions beneficially and advantageously regulate sleep when administered to an individual and are administered to a human or animal suffering from an irregular sleep or circadian rhythm or are administered in anticipation of the development of such an irregularity.
    Type: Grant
    Filed: February 22, 2005
    Date of Patent: September 21, 2010
    Assignee: LifeScape BioSciences Inc
    Inventor: Henry D. Cremisi
  • Publication number: 20040137080
    Abstract: A vitamin and mineral supplement regimen for dialysis patients. The regimen comprises first and second formulations. The first formulation contains selenium, and no zinc, and is administered on days of dialysis. The second formulation contains zinc, and no selenium, and is administered on days between dialysis. In addition, the second formulation contains more vitamin C and folic acid than the first formulation.
    Type: Application
    Filed: January 13, 2003
    Publication date: July 15, 2004
    Inventor: Henry D. Cremisi